M
Maria M. M. Santos
Researcher at University of Lisbon
Publications - 87
Citations - 2146
Maria M. M. Santos is an academic researcher from University of Lisbon. The author has contributed to research in topics: Apoptosis & Cancer. The author has an hindex of 23, co-authored 81 publications receiving 1801 citations. Previous affiliations of Maria M. M. Santos include Universidade Federal Rural do Rio de Janeiro & University of Barcelona.
Papers
More filters
Journal ArticleDOI
Squaric Acid/4-Aminoquinoline Conjugates: Novel Potent Antiplasmodial Agents.
Carlos Ribeiro,S. Praveen Kumar,Jiri Gut,Lídia Gonçalves,Philip J. Rosenthal,Rui Moreira,Maria M. M. Santos +6 more
TL;DR: New squaric acid/4-aminoquinoline hybrid compounds are synthesized by condensation of commercially available squarates with the heteroaromatic core of the antimalarial drugs chloroquine and primaquine.
Journal ArticleDOI
Growth exponents in surface models with non-active sites
TL;DR: In this article, the role played by the inactive sites present on the substrate of a growing surface was studied, where one particle sticks at the surface if the site where it falls is an active site, but allows the deposited particle to diffuse along the surface in accordance with some mechanism previously defined.
Journal ArticleDOI
Enantioselective Formal Synthesis of ent-Rhynchophylline (I) and ent-Isorhynchophylline (II).
Mercedes Amat,Carlos Ramos,Maria Pérez,Elies Molins,Pedro Florindo,Maria M. M. Santos,Joan Bosch +6 more
Journal ArticleDOI
Identification of tetracyclic lactams as NMDA receptor antagonists with potential application in neurological disorders.
Margarida Espadinha,Lucía Viejo,Ricardo M R M Lopes,Clara Herrera-Arozamena,Elies Molins,Daniel J. V. A. dos Santos,Daniel J. V. A. dos Santos,Lídia Gonçalves,María Isabel Rodríguez-Franco,Cristóbal de los Ríos,Maria M. M. Santos +10 more
TL;DR: The synthesis and pharmacological evaluation of a new scaffold with antagonistic activity for NMDAR is reported, and it is shown that the tetracyclic 1-aminoindan-2-ol derivatives are brain permeable and non-toxic, and promising hits for further optimization as modulators of the N MDAR function are identified.
Book ChapterDOI
PPIs as therapeutic targets for anticancer drug discovery: the case study of MDM2 and BET bromodomain inhibitors
TL;DR: An overview of the importance of PPIs as therapeutic targets for anticancer drug discovery is given and two case studies of the development of small molecule PPIs inhibitors are discussed in detail.